The digital health tech firm maintains its annual revenue forecast as it transitions its chief financial officer.
OptimizeRx reaffirmed its 2026 revenue outlook of $95M to $100M during its Q2 2026 earnings discussion. The guidance remains unchanged amid a leadership shift in the finance department.
The company previously projected the same revenue range in earlier communications. Analysts had anticipated no immediate adjustments to financial targets despite the CFO transition.
No immediate market reaction was detailed in the latest management commentary.